Fundraising Fox
BeyondSpring Pharmaceuticals
3 known investors
Find your way into BeyondSpring Pharmaceuticals
Sign up to see every warm intro you have to BeyondSpring Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BeyondSpring Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types. The compound demonstrates clinical benefit in extending overall survival and reducing severe chemotherapy-related neutropenia.
Investors · 3
Frequently asked questions
- What does BeyondSpring Pharmaceuticals do?
- Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types. The compound demonstrates clinical benefit in extending overall survival and reducing severe chemotherapy-related neutropenia.
- Who are BeyondSpring Pharmaceuticals's investors?
- BeyondSpring Pharmaceuticals's investors include Decheng Capital, EFung Capital, Sangel Capital.